Status:
COMPLETED
Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Intestinal Bacteria Flora Disturbance
Eligibility:
FEMALE
20-65 years
Phase:
NA
Brief Summary
In order to understand the life history of the breast milk flora, explore its composition, source of strains, and ability to colonize the baby's intestinal environment, to find out strains with the po...
Detailed Description
This is a double-blind and randomized study. After being discharged from the hospital, the subject was notified to consume the Babyguard breast milk probiotic daily for 1 month, and observe whether th...
Eligibility Criteria
Inclusion
- At least 20 years old, pregnant women with non-high-risk pregnancy risk assessed by obstetricians and gynecologists, healthy mothers and infants with no abnormal obstetric examination results
Exclusion
- Pregnant women who have used oral or injectable antibiotics within three months before delivery, or women who need a cesarean section for any reason during pregnancy
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04672889
Start Date
November 1 2021
End Date
November 30 2024
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Zhongzheng District, Taiwan, 100225